BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8932851)

  • 1. Vascular endothelial lesion in patients undergoing bone marrow transplantation.
    Richard S; Seigneur M; Blann A; Adams R; Renard M; Puntous M; Boiron JM; Amiral J; Reiffers J; Boisseau M
    Bone Marrow Transplant; 1996 Nov; 18(5):955-9. PubMed ID: 8932851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
    Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
    Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease.
    Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Hiller E
    Bone Marrow Transplant; 1997 May; 19(9):909-14. PubMed ID: 9156265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble adhesion molecules and endothelial cell damage in HIV infected patients.
    Seigneur M; Constans J; Blann A; Renard M; Pellegrin JL; Amiral J; Boisseau M; Conri C
    Thromb Haemost; 1997 Apr; 77(4):646-9. PubMed ID: 9134636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand factor as a marker of endothelial cell activation following BMT.
    Collins PW; Gutteridge CN; O'Driscoll A; Blair S; Jones L; Aitchison R; Kelsey SM; Chopra R; Goldstone A; Newland AC
    Bone Marrow Transplant; 1992 Dec; 10(6):499-506. PubMed ID: 1490199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of endothelial function in pediatric stem cell transplantation for acute leukemia.
    Luzzatto G; Cella G; Messina C; Randi ML; Sbarai A; Zanesco L
    Med Pediatr Oncol; 2003 Jan; 40(1):9-12. PubMed ID: 12426679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation.
    Testa S; Manna A; Porcellini A; Maffi F; Morstabilini G; Denti N; Macchi S; Rosti G; Porcellini G; Cassi D; Ferrari L
    Bone Marrow Transplant; 1996 Aug; 18(2):383-8. PubMed ID: 8864450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
    Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
    J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
    Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients.
    Grooteman MP; Gritters M; Wauters IM; Schalkwijk CG; Stam F; Twisk J; Ter Wee PM; Nubé MJ
    Nephrol Dial Transplant; 2005 Dec; 20(12):2751-8. PubMed ID: 16188898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The levels of soluble P-selectin, von Willebrand factor and thrombomodulin in patients with neurological complications after allogeneic bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Suehiro A; Kakishita E; Kanamaru A
    Bone Marrow Transplant; 1998 Apr; 21(8):809-13. PubMed ID: 9603405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium and bone marrow transplantation.
    Catani L; Gugliotta L; Vianelli N; Nocentini F; Baravelli S; Bandini G; Cirio TM; Tura S
    Bone Marrow Transplant; 1996 Feb; 17(2):277-80. PubMed ID: 8640179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
    Bloom BJ; Nelson SM; Eisenberg D; Alario AJ
    J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible evidence of endothelial cell activation and disturbance in thalassemia: an in vitro study.
    Butthep P; Bunyaratvej A; Funahara Y; Kitaguchi H; Fucharoen S; Sato S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1997; 28 Suppl 3():141-148A. PubMed ID: 9640617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can von Willebrand factor, platelet-endothelial cell adhesion molecule-1 and thrombomodulin be used as alternative markers of endothelial cell injury in human glomerulonephritis?
    Niemir ZI; Kubiak A; Olejniczak P; Nowak A; Czekalski S
    Rocz Akad Med Bialymst; 2004; 49():213-8. PubMed ID: 15631346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors.
    Hlubocká Z; Umnerová V; Heller S; Peleska J; Jindra A; Jáchymová M; Kvasnicka J; Horký K; Aschermann M
    J Hum Hypertens; 2002 Aug; 16(8):557-62. PubMed ID: 12149661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endothelial cell activation and/or injury in multiple sclerosis: analysis with von Willebrand factor and thrombomodulin].
    Kohriyama T; Maruyama H; Kurokawa K; Harada T; Nakamura S
    Rinsho Shinkeigaku; 1997 Apr; 37(4):287-91. PubMed ID: 9248336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.
    Meyer AA; Kundt G; Steiner M; Schuff-Werner P; Kienast W
    Pediatrics; 2006 May; 117(5):1560-7. PubMed ID: 16651309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.